Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Mucinous cystic neoplasms (MCNs) – Market Insight, Epidemiology, and Market Forecast – 2034
... cystic neoplasms (MCNs), historical and forecasted epidemiology as well as the Mucinous cystic neoplasms (MCNs) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Mucinous cystic neoplasms ... Read More
-
Myc Proto Oncogene Protein – Market Insight, Epidemiology, and Market Forecast – 2034
... Proto Oncogene Protein, historical and forecasted epidemiology as well as the Myc Proto Oncogene Protein market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Myc Proto Oncogene ... Read More
-
Myotubular Myopathy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Myotubular Myopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Myotubular Myopathy market report provides current treatment practices, emerging drugs, Myotubular ... Read More
-
Natural Killer (NK)-Cell Lymphoma – Market Insight, Epidemiology, and Market Forecast – 2034
... Killer (NK)-Cell Lymphoma, historical and forecasted epidemiology as well as the Natural Killer (NK)-Cell Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Natural Killer (NK)-Cell ... Read More
-
Niemann-Pick Disease (Type A) – Market Insight, Epidemiology, and Market Forecast – 2034
... Disease (Type A), historical and forecasted epidemiology as well as the Niemann-Pick Disease (Type A) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Niemann-Pick Disease (Type ... Read More
-
NR2E3 mutation-associated retinal degeneration – Market Insight, Epidemiology, and Market Forecast – 2034
... mutation-associated retinal degeneration, historical and forecasted epidemiology as well as the NR2E3 mutation-associated retinal degeneration market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The NR2E3 mutation-associated retinal ... Read More
-
Osteogenesis Imperfecta (OI) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Osteogenesis Imperfecta (OI) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Osteogenesis Imperfecta (OI) market report provides current ... Read More
-
Paget's Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Paget's Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Paget's Disease market report provides current treatment practices, emerging drugs, Paget's ... Read More
-
Pediatric Neuroblastoma – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Pediatric Neuroblastoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pediatric Neuroblastoma market report provides current treatment practices, emerging drugs, Pediatric ... Read More
-
Pharyngitis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Pharyngitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Pharyngitis market report provides current treatment practices, emerging drugs, Pharyngitis market share of the individual ... Read More
-
Primary Open Angle Glaucoma (POAG) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Primary Open Angle Glaucoma (POAG), historical and forecasted epidemiology as well as the Primary Open Angle Glaucoma (POAG) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Progressive Familial Intrahepatic Cholestasis (PFIC) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Progressive Familial Intrahepatic Cholestasis (PFIC), historical and forecasted epidemiology as well as the Progressive Familial Intrahepatic Cholestasis (PFIC) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Refractory Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Refractory Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Refractory Epilepsy market report provides current treatment practices, emerging drugs, Refractory ... Read More
-
Relapsed/Refractory Epstein Barr Virus – Market Insight, Epidemiology, and Market Forecast – 2034
... Epstein Barr Virus, historical and forecasted epidemiology as well as the Relapsed/Refractory Epstein Barr Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Relapsed/Refractory Epstein Barr ... Read More
-
Rhabdomyosarcoma – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Rhabdomyosarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Rhabdomyosarcoma market report provides current treatment practices, emerging drugs, Rhabdomyosarcoma market share of the individual ... Read More
-
Rubella – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Rubella market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Rubella market report provides current treatment practices, emerging drugs, Rubella market share of the individual ... Read More
-
Schistosomiasis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Schistosomiasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Schistosomiasis market report provides current treatment practices, emerging drugs, Schistosomiasis market share of the individual ... Read More
-
Scoliosis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Scoliosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Scoliosis market report provides current treatment practices, emerging drugs, Scoliosis market share of the individual ... Read More
-
Skin Neoplasms – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Skin Neoplasms market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Skin Neoplasms market report provides current treatment practices, emerging drugs, Skin ... Read More
-
Soft Tissue Sarcoma – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Soft Tissue Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Soft Tissue Sarcoma market report provides current ... Read More
-
Somatotropin Deficiency – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Somatotropin Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Somatotropin Deficiency market report provides current treatment practices, emerging drugs, Somatotropin ... Read More
-
Spinal Cord Injury (SCI) – Market Insight, Epidemiology, and Market Forecast – 2034
... Cord Injury (SCI), historical and forecasted epidemiology as well as the Spinal Cord Injury (SCI) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Spinal Cord Injury ... Read More
-
Syncope – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Syncope market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Syncope market report provides current treatment practices, emerging drugs, Syncope market share of the individual ... Read More
-
Syphilis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Syphilis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Syphilis market report provides current treatment practices, emerging drugs, Syphilis market share of the individual ... Read More
-
Tonsillitis – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Tonsillitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Tonsillitis market report provides current treatment practices, emerging drugs, Tonsillitis market share of the individual ... Read More
Research Assistance
